is pneumococcal prophylaxis justified?
Background: The high frequency of Streptococcus pneumoniae as a cause of bacteraemia in homozygous sickle cell (SS) disease and its effective prevention has led to the routine use of pneumococcal prophylaxis in developed countries. The reported infrequency of this organism as a cause of bacteraemia in SS disease in Africa raises questions on the epidemiology of bacterial infection and on the need for pneumococcal prophylaxis in that continent. Methods: A study of blood cultures in 155 Ugandan children (165 episodes) with SS disease and axillary temperatures of ≥38°C, attending the University Teaching Hospital in Kampala (Uganda, East Africa). Results: Positive blood cultures, obtained in 47/165 episodes, showed Staphylococcus aureus in 28 (60%) samples, Haemophilus influenzae in 9 (19%), Staphylococcus epidermidis in 4 (9%), and single cases of Streptococcus viridans, Escherichia coli and an unidentified Gram negative rod. Streptococcus pneumoniae was identified in only 3 (6%) episode.
Related Questions
- What is recommended for prophylaxis following varicella exposure for pregnant women without evidence of immunity?
- What is recommended for prophylaxis following varicella exposure for pregnant women without evidence of immunity?
- What are the possible side effects of V-Cillin K (Penicillin)?
- How much does Prevnar (Pneumococcal 7 Valent Vaccine) cost?
- How much does Prevnar (Pneumococcal 7 Valent Vaccine) cost?
- is pneumococcal prophylaxis justified?
